Drugmakers To Appeal $114M Verdict In AWP Case
GlaxoSmithKline and Novartis Pharmaceuticals Corp. vowed Wednesday to challenge a $114 million verdict handed down by an Alabama jury, which found the companies had defrauded the state as part of a...To view the full article, register now.
Already a subscriber? Click here to view full article